MTHFR和ABCB1多态因子与血液性恶性瘤患者的毒性相关,这些患者接受高剂量甲甲酸盐治疗
Yaling Shi1, Nan Zhou1, Lu Cao1
1Department of Pharmacy, ShaanXi Provincial People's Hospital, 256 Youyixi Road, Beilin District, Xi'an, ShaanXi Province, China.
Scientific reports
|December 17, 2025
概括
在MTHFR和ABCB1的基因变异影响血液癌症患者高剂量甲状腺素毒性. 年龄和MTHFR 1298AC是延迟药物消除的关键因素,有助于个性化治疗策略.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 高剂量甲状腺素 (HD-MTX) 对于血液性恶性瘤至关重要,但会导致毒性.
- 药物代谢酶的遗传变异 (多态) 可能会影响MTX的疗效和毒性.
- 之前对MTHFR C677T,MTHFR A1298C和ABCB1 C3435T多态性和MTX毒性的研究尚未得出结论.
研究的目的:
- 为了研究MTHFR C677T,MTHFR A1298C和ABCB1 C3435T基因多态性和HD-MTX相关的毒性和血液性恶性瘤的成年患者的延迟消除之间的关联.
- 确定延迟MTX消除的独立风险因素.
主要方法:
- 分析了接受HD-MTX的111名患有血液性恶性瘤的成年患者队列.
- 对MTHFR C677T,MTHFR A1298C和ABCB1 C3435T多态性进行了基因定型.
- 使用统计分析来评估多形态,临床因素,MTX毒性和消除之间的关系.
主要成果:
- 在这组患者中,MTHFR C677T,MTHFR A1298C和ABCB1 C3435T基因多态性与MTX相关的毒性显著相关.
- 年龄 (≥60岁) 和MTHFR A1298C多态性被确定为延迟MTX消除的独立风险因素.
- 这些发现表明MTX毒性和药物清除变化的遗传倾向.
结论:
- MTHFR C677T,MTHFR A1298C和ABCB1 C3435T多态性在患有血液性恶性瘤的患者的MTX毒性和消除中发挥作用.
- 识别具有特定多态性和年龄较大的患者可以帮助预测和管理延迟的MTX消除.
- 这些遗传标记物为个性化HD-MTX治疗提供了潜在的潜力,以减轻毒性并改善患者的治疗结果.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Mismatch Repair
6.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.2K
Mismatch Repair
43.4K
Overview
43.4K
Translation
154.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.9K
Translation
17.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.4K
Phase II Reactions: Methylation Reactions
656
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
656


